Mega Lifesciences (Thailand) Management Evaluation
| MEGA Stock | THB 33.75 0.50 1.50% |
Mega Lifesciences employs about 21 people. The company is managed by 9 executives with a total tenure of roughly 76 years, averaging almost 8.0 years of service per executive, having 2.33 employees per reported executive. Inspection of Mega Lifesciences' management performance can provide insight into the company performance.
| Vivek Dhawan CEO CEO, Chief Coach, Director and Member of Remuneration and Nomination Committee |
| Paramjit Sawhney President President of International |
Mega |
Mega Lifesciences Management Team Effectiveness
The company has return on total asset (ROA) of 0.1239 % which means that it generated a profit of $0.1239 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2915 %, meaning that it generated $0.2915 on every $100 dollars invested by stockholders. Mega Lifesciences' management efficiency ratios could be used to measure how well Mega Lifesciences manages its routine affairs as well as how well it operates its assets and liabilities.Mega Lifesciences Workforce Comparison
Mega Lifesciences Public is regarded third in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 215. Mega Lifesciences holds roughly 21.0 in number of employees claiming about 10% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Mega Lifesciences Public Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Mega Lifesciences Public Price Series Summation is a cross summation of Mega Lifesciences price series and its benchmark/peer.
Mega Lifesciences Notable Stakeholders
A Mega Lifesciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mega Lifesciences often face trade-offs trying to please all of them. Mega Lifesciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mega Lifesciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vivek Dhawan | CEO, Chief Coach, Director and Member of Remuneration and Nomination Committee | Profile | |
| Paramjit Sawhney | President of International | Profile | |
| Thomas Abraham | CFO and Director | Profile | |
| Girish Wadhwa | Managing Director of Myanmar | Profile | |
| Duangnapa Tongsiri | Pres Thailand | Profile | |
| Apichai Chanjarusiri | Manufacturing Thailand | Profile | |
| Manoj Gurbuxani | Deputy Officer | Profile | |
| Deepak Panjwani | Chief Officer | Profile | |
| Sujintana Boonworapat | Co Sec | Profile |
About Mega Lifesciences Management Performance
The success or failure of an entity such as Mega Lifesciences Public often depends on how effective the management is. Mega Lifesciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mega management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mega management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast moving consumer goods. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited. MEGA LIFESCIENCES operates under Drug Manufacturers - Major classification in Thailand and is traded on Stock Exchange of Thailand.
Mega Lifesciences Workforce Analysis
Traditionally, organizations such as Mega Lifesciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mega Lifesciences within its industry.Mega Lifesciences Manpower Efficiency
Return on Mega Lifesciences Manpower
| Revenue Per Employee | 673.1M | |
| Revenue Per Executive | 1.6B | |
| Net Income Per Employee | 92.7M | |
| Net Income Per Executive | 216.3M | |
| Working Capital Per Employee | 150.1M | |
| Working Capital Per Executive | 350.2M |
Other Information on Investing in Mega Stock
Mega Lifesciences financial ratios help investors to determine whether Mega Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mega with respect to the benefits of owning Mega Lifesciences security.